In this interactive recording of a live CCO webinar, experts discuss current best practices and emerging strategies for using immune checkpoint inhibitors to treat patients with hepatobiliary cancers.
Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with advanced hepatocellular carcinoma.
Download this slideset for expert perspectives on emerging strategies in using immune checkpoint inhibitors for patients with early- and intermediate-stage hepatocellular carcinoma and advanced biliary tract cancers.
Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with hepatocellular carcinoma and biliary tract cancers.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.